A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer

NCT00116779 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
127
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ferring Pharmaceuticals